Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The macrophage activation marker sCD163 in acute and chronic graft-versus-host disease after pediatric hematopoietic stem cell transplantation

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Soluble CD163 and graft-versus-host disease.

Data availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.


  1. Zeiser R, Blazar BR. Acute graft-versus-host disease - Biologic process, prevention, and therapy. N Engl J Med. 2017;377:2167–79.

  2. Jardine L, Cytlak U, Gunawan M, Reynolds G, Green K, Wang XN, et al. Donor monocyte-derived macrophages promote human acute graft-versus-host disease. J Clin Investig. 2020;130:4574–86.

    Article  CAS  Google Scholar 

  3. Cooke KR, Luznik L, Sarantopoulos S, Hakim FT, Jagasia M, Fowler DH, et al. The biology of chronic graft-versus-host disease: a task force report from the national institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. Biol Blood Marrow Transpl. 2017;23:211–34.

    Article  Google Scholar 

  4. Skytthe MK, Graversen JH, Moestrup SK. Targeting of CD163+ macrophages in inflammatory and malignant diseases. Int J Mol Sci. 2020;21:5497.

    Article  CAS  Google Scholar 

  5. Nielsen MC, Hvidbjerg Gantzel R, Clària J, Trebicka J, Møller HJ, Grønbæk H. Macrophage activation markers, CD163 and CD206, in acute-on-chronic liver failure. Cells. 2020;9:1175.

    Article  CAS  Google Scholar 

  6. Kazankov K, Alisi A, Møller HJ, De Vito R, Rittig S, Mahler B, et al. Macrophage markers are poorly associated with liver histology in children with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr. 2018;67:635–42.

    Article  CAS  Google Scholar 

  7. Møller HJ, Hald K, Moestrup SK. Characterization of an enzyme-linked immunosorbent assay for soluble CD163. Scand J Clin Lab Invest. 2002;62:293–9.

    Article  Google Scholar 

  8. Rødgaard-Hansen S, Rafique A, Christensen PA, Maniecki MB, Sandahl TD, Nexø E, et al. A soluble form of the macrophage-related mannose receptor (MR/CD206) is present in human serum and elevated in critical illness. Clin Chem Lab Med. 2014;52:453–61.

    Article  Google Scholar 

  9. Schoemans HM, Lee SJ, Ferrara JL, Wolff D, Levine JE, Schultz KR, et al. EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment. Bone Marrow Transpl. 2018;53:1401–15.

    Article  Google Scholar 

  10. Nishiwaki S, Terakura S, Ito M, Goto T, Seto A, Watanabe K, et al. Impact of macrophage infiltration of skin lesions on survival after allogeneic stem cell transplantation: a clue to refractory graft-versus-host disease. Blood. 2009;114:3113–6.

    Article  CAS  Google Scholar 

  11. Imahashi N, Inamoto Y, Ito M, Koyama D, Goto T, Onodera K, et al. Clinical significance of hemophagocytosis in BM clot sections during the peri-engraftment period following allogeneic hematopoietic SCT. Bone Marrow Transpl. 2012;47:387–94.

    Article  CAS  Google Scholar 

  12. Seno K, Yasunaga M, Kajiya H, Izaki-Hagio K, Morita H, Yoneda M, et al. Dynamics of M1 macrophages in oral mucosal lesions during the development of acute graft- versus -host disease in rats. Clin Exp Immunol. 2017;190:315–27.

    Article  CAS  Google Scholar 

  13. Villani AC, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes and progenitors. Science. 2017;356:eaah4573.

    Article  Google Scholar 

  14. Alexander KA, Flynn R, Lineburg KE, Kuns RD, Teal BE, Olver SD, et al. CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease. J Clin Investig. 2014;124:4266–80.

    Article  Google Scholar 

  15. Inamoto Y, Martin PJ, Paczesny S, Tabellini L, Momin AA, Mumaw CL, et al. Association of plasma CD163 concentration with de novo–onset chronic graft-versus-host disease. Biol Blood Marrow Transpl. 2017;23:1250–6.

    Article  CAS  Google Scholar 

Download references


This study was supported by The Danish Cancer Society (R228-A13611).

Author information

Authors and Affiliations



KM and HG conceived and designed the study. LLFH, KK, SW, SR, NG and MI collected the patient samples and clinical data. HJM and HG measured the plasma levels of macrophage activation markers. LLFH, KK and KM analyzed the data and drafted the manuscript. All authors revised the manuscript.

Corresponding author

Correspondence to Katrine Kielsen.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hergel, L.L.F., Kielsen, K., Weischendorff, S. et al. The macrophage activation marker sCD163 in acute and chronic graft-versus-host disease after pediatric hematopoietic stem cell transplantation. Bone Marrow Transplant (2023).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI:


Quick links